Guangyu Xu

Characterization of FGF401 as a reversible covalent inhibitor of fibroblast growth factor receptor 4.

Yongheng Chen, Zhuchu Chen, Lin Chen, 2019, Chemical communications.

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors

Yongheng Chen, Zhuchu Chen, S. Dai, 2019, Cells.

LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance.

Yongheng Chen, Zhuchu Chen, Lin Chen, 2018, Chemical communications.

MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma

Hao Xu, Xiaohu Zhou, Yuan Ding, 2022, Frontiers in Pharmacology.

Structure-based design of a dual-warhead covalent inhibitor of FGFR4

Yongheng Chen, S. Dai, Jun Li, 2022, Communications Chemistry.

Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment

Yongheng Chen, Zhuchu Chen, Maojun Zhou, 2021, Aging.

LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance.

Yongheng Chen, Zhuchu Chen, Lin Chen, 2018, Chemical communications.